HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bondioni, S. Articles by Lania, A. G. Search for Related Content PubMed PubMed Citation Articles by Bondioni, S. Articles by Lania, A. G.

---

ORIGINAL RESEARCH ARTICLE

Effect of 9-cis Retinoic Acid on Dopamine D2 Receptor Expression in Pituitary Adenoma Cells

Sara Bondioni^*, Anita R. Angioni^*, Sabrina Corbetta, Marco Locatelli, Stefano Ferrero, Emanuele Ferrante^*, Giovanna Mantovani^*, Luca Olgiati^*, Paolo Beck-Peccoz^*, Anna Spada^* and Andrea G. Lania^*,1

^* Endocrine Unit, Department of Medical Sciences, University of Milan, Fondazione Ospedale Maggiore IRCCS, 20122 Milan, Italy; Endocrine Unit, Department of Medical-Surgical Sciences, University of Milan, Policlico San Donato IRCCS, San Donato Milanese, 20122 Milan, Italy; Department of Neurosurgery, Fondazione Ospedale Maggiore IRCCS, 20122 Milan, Italy; and Pathology Unit, Department of Medicine, Surgery and Dentistry, University of Milan, A.O. San Paolo and Fondazione Ospedale Maggiore IRCCS, 20122 Milan, Italy

To whom requests for reprints should be addressed at ¹ The Department of Medical Sciences, University of Milan, Endocrine Unit, Fondazione Ospedale Maggiore IRCCS, Via F.Sforza 35, 20122 Milan, Italy. E-mail: andrea.lania{at}unimi.it

The dopamine receptor subtype 2 (D2R) promoter contains a functional retinoic acid response element involved in the control of D2R expression. The aim of the study was to evaluate the effect of 9-cis retinoic acid (9-cis RA) on D2R protein expression in human pituitary adenomas and GH3 cell line. Treatment with 9-cis RA (100 nM for 48 hrs) caused a 109 ± 32% increase of basal D2R levels in five of eight growth hormone (GH)-secreting adenomas (GH-omas), a 129 ± 28% increase in 7 of 11 nonfunctioning adenomas, and no effect in two resistant prolactinomas by Western blotting. The lack of D2R induction in some tumors was not associated with a different pattern of retinoid x receptor (RXR) and retinoic acid receptor (RAR) isoform expression that was similar in all tumors by immunohistochemistry. While the induction of D2R did not affect the slight but significant inhibitory effect exerted by dopamine (10 nM) on in vitro GH release by GH-oma cultured cells, in pituitary GH3 cell lines cis-9 RA enhanced the dopamine-induced inhibition of in vitro GH release (% inhibition: 16 ± 2 versus 26 ± 5, P < 0.05), cell proliferation (25 ± 2% versus 44 ± 5%, P < 0.05) and cell viability (16 ± 0.8% versus 29 ± 1%, P < 0.05), likely by activating caspase-3 (28 ± 3% versus basal, P < 0.05). In conclusion, this study provides novel evidence for a permissive role of retinoids on the expression of D2R in a good proportion of pituitary tumors and on the generation of pro-apoptotic signals in GH3 cell line.

Key Words: retinoic acid • D2 receptor • pituitary tumor • GH3 cell • apoptosis